718 related articles for article (PubMed ID: 34782627)
1. SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis.
Yoo JS; Sasaki M; Cho SX; Kasuga Y; Zhu B; Ouda R; Orba Y; de Figueiredo P; Sawa H; Kobayashi KS
Nat Commun; 2021 Nov; 12(1):6602. PubMed ID: 34782627
[TBL] [Abstract][Full Text] [Related]
2. NLRC5/MHC class I transactivator: A key target for immune escape by SARS-CoV-2.
Zhu B; Ouda R; Kasuga Y; de Figueiredo P; Kobayashi KS
Bioessays; 2024 Apr; 46(4):e2300109. PubMed ID: 38461519
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus Porcine Deltacoronavirus Upregulates MHC Class I Expression through RIG-I/IRF1-Mediated NLRC5 Induction.
Liu X; Yin L; Xue M; Chen J; Li L; Fu F; Feng L; Liu P
J Virol; 2022 Apr; 96(7):e0015822. PubMed ID: 35311551
[TBL] [Abstract][Full Text] [Related]
4. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes.
Meissner TB; Li A; Biswas A; Lee KH; Liu YJ; Bayir E; Iliopoulos D; van den Elsen PJ; Kobayashi KS
Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13794-9. PubMed ID: 20639463
[TBL] [Abstract][Full Text] [Related]
5. Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.
Guo X; Liu T; Shi H; Wang J; Ji P; Wang H; Hou Y; Tan RX; Li E
J Virol; 2015 Aug; 89(15):7636-45. PubMed ID: 25972545
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
Miorin L; Kehrer T; Sanchez-Aparicio MT; Zhang K; Cohen P; Patel RS; Cupic A; Makio T; Mei M; Moreno E; Danziger O; White KM; Rathnasinghe R; Uccellini M; Gao S; Aydillo T; Mena I; Yin X; Martin-Sancho L; Krogan NJ; Chanda SK; Schotsaert M; Wozniak RW; Ren Y; Rosenberg BR; Fontoura BMA; García-Sastre A
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28344-28354. PubMed ID: 33097660
[TBL] [Abstract][Full Text] [Related]
7. CITA/NLRC5: A critical transcriptional regulator of MHC class I gene expression.
Downs I; Vijayan S; Sidiq T; Kobayashi KS
Biofactors; 2016 Jul; 42(4):349-57. PubMed ID: 27087581
[TBL] [Abstract][Full Text] [Related]
8. ORF6, a repressor of the MHC class I pathway: new molecular target for SARS-CoV-2 drug discovery?
Zhu B; Ouda R; de Figueiredo P; Kobayashi KS
Expert Opin Ther Targets; 2023; 27(8):639-644. PubMed ID: 37602463
[No Abstract] [Full Text] [Related]
9. NLRC5: a key regulator of MHC class I-dependent immune responses.
Kobayashi KS; van den Elsen PJ
Nat Rev Immunol; 2012 Dec; 12(12):813-20. PubMed ID: 23175229
[TBL] [Abstract][Full Text] [Related]
10. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane.
Frieman M; Yount B; Heise M; Kopecky-Bromberg SA; Palese P; Baric RS
J Virol; 2007 Sep; 81(18):9812-24. PubMed ID: 17596301
[TBL] [Abstract][Full Text] [Related]
11. The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity.
Meissner TB; Li A; Liu YJ; Gagnon E; Kobayashi KS
Biochem Biophys Res Commun; 2012 Feb; 418(4):786-91. PubMed ID: 22310711
[TBL] [Abstract][Full Text] [Related]
12. NLRC5: a newly discovered MHC class I transactivator (CITA).
Meissner TB; Li A; Kobayashi KS
Microbes Infect; 2012 Jun; 14(6):477-84. PubMed ID: 22209772
[TBL] [Abstract][Full Text] [Related]
13. LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer.
Zhan L; Zhang J; Zhang J; Liu X; Zhu S; Shi Y; He Y; Wang W; Fan Y; Tang Z; Chen G; Wei B; Cao Y
Cancer Lett; 2022 Mar; 529():37-52. PubMed ID: 34974132
[TBL] [Abstract][Full Text] [Related]
14. NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner.
Neerincx A; Rodriguez GM; Steimle V; Kufer TA
J Immunol; 2012 May; 188(10):4940-50. PubMed ID: 22490867
[TBL] [Abstract][Full Text] [Related]
15. Sarbecovirus ORF6 proteins hamper induction of interferon signaling.
Kimura I; Konno Y; Uriu K; Hopfensperger K; Sauter D; Nakagawa S; Sato K
Cell Rep; 2021 Mar; 34(13):108916. PubMed ID: 33765414
[TBL] [Abstract][Full Text] [Related]
16. NLRC5/MHC class I transactivator is a target for immune evasion in cancer.
Yoshihama S; Roszik J; Downs I; Meissner TB; Vijayan S; Chapuy B; Sidiq T; Shipp MA; Lizee GA; Kobayashi KS
Proc Natl Acad Sci U S A; 2016 May; 113(21):5999-6004. PubMed ID: 27162338
[TBL] [Abstract][Full Text] [Related]
17. The balance between nuclear import and export of NLRC5 regulates MHC class I transactivation.
Zhu B; Ouda R; An N; Tanaka T; Kobayashi KS
J Biol Chem; 2024 May; 300(5):107205. PubMed ID: 38519032
[TBL] [Abstract][Full Text] [Related]
18. Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.
Vijayan S; Sidiq T; Yousuf S; van den Elsen PJ; Kobayashi KS
Immunogenetics; 2019 Mar; 71(3):273-282. PubMed ID: 30706093
[TBL] [Abstract][Full Text] [Related]
19. The Obligate Intracellular Bacterium
Rodino KG; Adcox HE; Martin RK; Patel V; Conrad DH; Carlyon JA
Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30559222
[No Abstract] [Full Text] [Related]
20. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication.
Miyamoto Y; Itoh Y; Suzuki T; Tanaka T; Sakai Y; Koido M; Hata C; Wang CX; Otani M; Moriishi K; Tachibana T; Kamatani Y; Yoneda Y; Okamoto T; Oka M
Commun Biol; 2022 May; 5(1):483. PubMed ID: 35590097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
